{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:43:19Z","timestamp":1786984999132,"version":"build-2736575974"},"reference-count":89,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,4,4]],"date-time":"2018-04-04T00:00:00Z","timestamp":1522800000000},"content-version":"am","delay-in-days":246,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000005","name":"Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-16-1-0641"],"award-info":[{"award-number":["W81XWH-16-1-0641"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007081","name":"Perricone Family Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007081","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008307","name":"Beckman Research Institute of City of Hope","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008307","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.bbcan.2017.03.009","type":"journal-article","created":{"date-parts":[[2017,3,27]],"date-time":"2017-03-27T23:32:59Z","timestamp":1490657579000},"page":"167-175","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Targeting the mercapturic acid pathway and vicenin-2 for prevention of prostate cancer"],"prefix":"10.1016","volume":"1868","author":[{"given":"Sharad S.","family":"Singhal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Divya","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Preeti","family":"Singhal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Awasthi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyotsana","family":"Singhal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Horne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbcan.2017.03.009_bb0005","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0140-6736(14)61947-4","article-title":"Prostate cancer","volume":"387","author":"Attard","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.bbcan.2017.03.009_bb0010","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/nrclinonc.2014.68","article-title":"High-risk prostate cancer-classification and therapy","volume":"11","author":"Chang","year":"2014","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.bbcan.2017.03.009_bb0015","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1056\/NEJMra021562","article-title":"Prostate cancer","volume":"349","author":"Nelson","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbcan.2017.03.009_bb0020","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3389\/fendo.2012.00128","article-title":"Genomic and epigenomic alterations in prostate cancer","volume":"3","author":"Aschelter","year":"2012","journal-title":"Front. Endocrinol."},{"issue":"18","key":"10.1016\/j.bbcan.2017.03.009_bb0025","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1101\/gad.1965810","article-title":"Molecular genetics of prostate cancer: new prospects for old challenges","volume":"24","author":"Shen","year":"2010","journal-title":"Genes Dev."},{"issue":"1","key":"10.1016\/j.bbcan.2017.03.009_bb0030","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1677\/erc.0.0090061","article-title":"Mechanisms involved in the progression of androgen-independent prostate cancers: it is not only the cancer cell's fault","volume":"9","author":"Arnold","year":"2002","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.bbcan.2017.03.009_bb0035","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/35094009","article-title":"The development of androgen-independent prostate cancer","volume":"1","author":"Feldman","year":"2001","journal-title":"Nat. Rev. Cancer"},{"issue":"6","key":"10.1016\/j.bbcan.2017.03.009_bb0040","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1158\/1078-0432.CCR-06-0067","article-title":"Mechanisms underlying the development of androgen-independent prostate cancer","volume":"12","author":"Pienta","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2017.03.009_bb0045","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/ng1935","article-title":"Integrative molecular concept modeling of prostate cancer progression","volume":"39","author":"Tomlins","year":"2007","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbcan.2017.03.009_bb0050","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.humpath.2010.02.011","article-title":"Multifocal prostate cancer: biologic, prognostic, and therapeutic I mplications","volume":"41","author":"Andreoiu","year":"2010","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.bbcan.2017.03.009_bb0055","first-page":"209","article-title":"Prostate cancer multifocality: impact on cancer biology and treatment recommendations","volume":"52","author":"Delacroix","year":"2010","journal-title":"Panminerva Med."},{"key":"10.1016\/j.bbcan.2017.03.009_bb0060","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1016\/j.juro.2010.06.137","article-title":"Multifocal high grade prostatic intraepithelial neoplasia is a risk factor for subsequent prostate cancer","volume":"184","author":"Lee","year":"2010","journal-title":"J. Urol."},{"key":"10.1016\/j.bbcan.2017.03.009_bb0065","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.ejca.2005.02.016","article-title":"Docetaxel administration schedule: from fever to tears? A review of randomised studies","volume":"41","author":"Engels","year":"2005","journal-title":"Eur. J. Cancer"},{"issue":"5","key":"10.1016\/j.bbcan.2017.03.009_bb0070","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/cas.12647","article-title":"Pharmacokinetics, dynamics and toxicity of docetaxel: why the Japanese dose differs from the western dose","volume":"106","author":"Kenmotsu","year":"2015","journal-title":"Cancer Sci."},{"issue":"3","key":"10.1016\/j.bbcan.2017.03.009_bb0075","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/embor.2009.12","article-title":"Natural products and drug discovery. Can thousands of years of ancient medical knowledge lead us to new and powerful drug combinations in the fight against cancer and dementia?","volume":"10","author":"Ji","year":"2009","journal-title":"EMBO Rep."},{"issue":"6","key":"10.1016\/j.bbcan.2017.03.009_bb0080","doi-asserted-by":"crossref","first-page":"3670","DOI":"10.1016\/j.bbagen.2013.02.008","article-title":"Natural products: a continuing source of novel drug leads","volume":"1830","author":"Cragg","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"issue":"2","key":"10.1016\/j.bbcan.2017.03.009_bb0085","first-page":"172","article-title":"Role of natural products in drug discovery process","volume":"6","author":"Siddiqui","year":"2014","journal-title":"Int. J. Drug Dev. Res."},{"issue":"10","key":"10.1016\/j.bbcan.2017.03.009_bb0090","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.2174\/187152012803833026","article-title":"Plants against cancer: a review on natural phytochemicals in preventing and treating cancers and their druggability","volume":"12","author":"Wang","year":"2012","journal-title":"Anti Cancer Agents Med. Chem."},{"key":"10.1016\/j.bbcan.2017.03.009_bb0095","doi-asserted-by":"crossref","first-page":"552","DOI":"10.3390\/nu8090552","article-title":"Anticancer efficacy of polyphenols and their combinations","volume":"8","author":"Niedzwiecki","year":"2016","journal-title":"Nutrients"},{"issue":"4","key":"10.1016\/j.bbcan.2017.03.009_bb0100","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1080\/01926230701320337","article-title":"Apoptosis: a review of programmed cell death","volume":"35","author":"Elmore","year":"2007","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.bbcan.2017.03.009_bb0105","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1146\/annurev-genet-102108-134850","article-title":"The role of mitochondria in apoptosis","volume":"43","author":"Wang","year":"2009","journal-title":"Annu. Rev. Genet."},{"key":"10.1016\/j.bbcan.2017.03.009_bb0110","doi-asserted-by":"crossref","first-page":"6836","DOI":"10.1158\/1078-0432.CCR-06-1273","article-title":"Diallyl trisulfide suppresses growth of PC-3 human prostate cancer xenograft in vivo in association with Bax and Bak induction","volume":"12","author":"Xiao","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2017.03.009_bb0115","first-page":"383","article-title":"The glutathione S-transferases: a group of multi-functional detoxification protein","volume":"46","author":"Jakoby","year":"1978","journal-title":"Adv. Enzymol. Mol. Biol."},{"key":"10.1016\/j.bbcan.2017.03.009_bb0120","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/0020-711X(94)90050-7","article-title":"Human glutathione S-transferases","volume":"26","author":"Awasthi","year":"1994","journal-title":"Int. J. BioChemiPhysics"},{"key":"10.1016\/j.bbcan.2017.03.009_bb0125","doi-asserted-by":"crossref","first-page":"445","DOI":"10.3109\/10409239509083491","article-title":"The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance","volume":"30","author":"Hayes","year":"1995","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"key":"10.1016\/j.bbcan.2017.03.009_bb0130","doi-asserted-by":"crossref","first-page":"19008","DOI":"10.1074\/jbc.M112472200","article-title":"Regulation of endocytosis of activin type II receptors by a novel PDZ protein through Ral\/Ral-binding protein 1-dependent pathway","volume":"277","author":"Matsuzaki","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbcan.2017.03.009_bb0135","first-page":"982","article-title":"The role of Ral A in epidermal growth factor receptor-regulated cell motility","volume":"62","author":"Gildea","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2017.03.009_bb0140","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/ijc.11260","article-title":"Transport of glutathione-conjugates and chemotherapeutic drugs by RLIP76: a novel link between G-protein and tyrosine-kinase signaling and drug-resistance","volume":"106","author":"Awasthi","year":"2003","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbcan.2017.03.009_bb0145","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1038\/sj.leu.2402945","article-title":"Signal transduction mediated by the Ras\/Raf\/MEK\/ERK pathway from cytokine receptors to transcription factors: potential targeting for therapeutic intervention","volume":"17","author":"Chang","year":"2003","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.bbcan.2017.03.009_bb0150","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.cell.2012.03.003","article-title":"MYC on the path to cancer","volume":"149","author":"Dang","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2017.03.009_bb0155","doi-asserted-by":"crossref","first-page":"4372","DOI":"10.1158\/1078-0432.CCR-08-0145","article-title":"RLIP76 and cancer","volume":"14","author":"Awasthi","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2017.03.009_bb0160","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.bcp.2008.10.006","article-title":"RLIP76: a novel glutathione-conjugate and multi-drug transporter","volume":"77","author":"Singhal","year":"2009","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbcan.2017.03.009_bb0165","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.bcp.2011.07.078","article-title":"Anti-cancer effects of novel flavonoid vicenin-2 as a single agent and in synergistic combination with docetaxel in prostate cancer","volume":"82","author":"Nagaprashantha","year":"2011","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbcan.2017.03.009_bb0170","doi-asserted-by":"crossref","first-page":"6022","DOI":"10.1158\/0008-5472.CAN-05-0968","article-title":"RALBP1 is a major determinant of radiation sensitivity","volume":"65","author":"Awasthi","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2017.03.009_bb0175","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.ijrobp.2008.06.1497","article-title":"RLIP76 in defense of radiation poisoning","volume":"72","author":"Singhal","year":"2008","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.bbcan.2017.03.009_bb0180","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1158\/1535-7163.MCT-10-0699","article-title":"Glutathione-conjugate transport by RLIP76 is required for clathrin-dependent endocytosis and chemical carcinogenesis","volume":"10","author":"Singhal","year":"2011","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.bbcan.2017.03.009_bb0185","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.bcp.2008.11.013","article-title":"Regression of prostate cancer xenografts by RLIP76 depletion","volume":"77","author":"Singhal","year":"2009","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbcan.2017.03.009_bb0190","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0378-8741(96)83992-4","article-title":"Evaluation of anti-inflammatory potential of fixed oil of ocimum sanctum (holybasil) and its possible mechanism of action","volume":"54","author":"Singh","year":"1996","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.bbcan.2017.03.009_bb0195","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/BF02436038","article-title":"Effect of tulasi (ocimum sanctum) leaf powder supplementation on blood sugar levels, serum lipids and tissue lipids in diabetic rats","volume":"50","author":"Rai","year":"1997","journal-title":"Plant Foods Hum. Nutr."},{"issue":"6","key":"10.1016\/j.bbcan.2017.03.009_bb0200","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1021\/np100937e","article-title":"Vicenin-2, a potential anti-inflammatory constituent of urtica circularis","volume":"74","author":"Marrassini","year":"2011","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.bbcan.2017.03.009_bb0205","first-page":"105","article-title":"The antioxidant flavonoids, orientin and vicenin enhance repair of radiation-induced damage","volume":"1","author":"Satyamitra","year":"2014","journal-title":"SAJ Pharm. Pharmacol."},{"key":"10.1016\/j.bbcan.2017.03.009_bb0210","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.fct.2014.03.042","article-title":"Vicenin-2 isolated from Artemisia capillaris exhibited potent anti-glycation properties","volume":"69","author":"Islam","year":"2014","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.bbcan.2017.03.009_bb0215","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s00011-015-0906-x","article-title":"Anti-inflammatory effects of vicenin-2 and scolymoside on polyphosphate-mediated vascular inflammatory responses","volume":"65","author":"Lee","year":"2016","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.bbcan.2017.03.009_bb0220","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jep.2004.02.029","article-title":"Evaluation of anti-ulcerogenic and ulcer-healing properties of Ocimum sanctum Linn","volume":"93","author":"Dharmani","year":"2004","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.bbcan.2017.03.009_bb0225","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jep.2003.09.034","article-title":"Ethanolic extract of Ocimum sanctum leaves partially attenuates streptozotocin-induced alterations in glycogen content and carbohydrate metabolism in rats","volume":"90","author":"Vats","year":"2004","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.bbcan.2017.03.009_bb0230","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0891-5849(91)90077-G","article-title":"An overview of the relationship between oxidative stress and chemical carcinogenesis","volume":"10","author":"Trush","year":"1991","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bbcan.2017.03.009_bb0235","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1053\/j.seminoncol.2004.03.044","article-title":"COX-2 inhibitors and other nonsteroidal anti-inflammatory drugs in genitourinary cancer","volume":"31","author":"Sabichi","year":"2004","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.bbcan.2017.03.009_bb0240","first-page":"933","article-title":"Suppression of advanced human prostate tumor growth in athymic mice by silibinin feeding is associated with reduced cell proliferation, increased apoptosis, and inhibition of angiogenesis","volume":"12","author":"Singh","year":"2003","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"issue":"6","key":"10.1016\/j.bbcan.2017.03.009_bb0245","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1007\/s40495-015-0034-x","article-title":"Broccoli-derived sulforaphane and chemoprevention of prostate cancer: from bench to bedside","volume":"1","author":"Amjad","year":"2015","journal-title":"Curr. Pharmacol. Rep."},{"key":"10.1016\/j.bbcan.2017.03.009_bb0250","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S1368-8375(98)00035-9","article-title":"Chemopreventive effect of ocimum sanctum on DMBA-induced hamster buccal pouch carcinogenesis","volume":"35","author":"Karthikeyan","year":"1999","journal-title":"Oral Oncol."},{"key":"10.1016\/j.bbcan.2017.03.009_bb0255","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1667\/RR3263","article-title":"Protection of mouse bone marrow against radiation-induced chromosome damage and stem cell death by the ocimum flavonoids orientin and vicenin","volume":"163","author":"Nayak","year":"2005","journal-title":"Radiat. Res."},{"key":"10.1016\/j.bbcan.2017.03.009_bb0260","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S1383-5718(01)00263-7","article-title":"Radiation protection of human lymphocyte chromosomes in vitro by orientin and vicenin","volume":"498","author":"Vrinda","year":"2001","journal-title":"Mutat. Res."},{"issue":"4","key":"10.1016\/j.bbcan.2017.03.009_bb0265","first-page":"291","article-title":"The science behind sacredness of Tulsi (Ocimum Sanctum Linn.)","volume":"53","author":"Mondal","year":"2009","journal-title":"Indian J. Physiol. Pharmacol."},{"key":"10.1016\/j.bbcan.2017.03.009_bb0270","doi-asserted-by":"crossref","first-page":"5165","DOI":"10.1158\/0008-5472.CAN-12-0468","article-title":"RALBP1\/RLIP76 depletion in mice suppresses tumor growth by inhibiting tumor neo-vascularization","volume":"72","author":"Lee","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2017.03.009_bb0275","doi-asserted-by":"crossref","first-page":"4244","DOI":"10.1158\/0008-5472.CAN-08-3521","article-title":"RLIP76: a target for kidney cancer therapy","volume":"69","author":"Singhal","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2017.03.009_bb0280","doi-asserted-by":"crossref","first-page":"4382","DOI":"10.1158\/0008-5472.CAN-06-4124","article-title":"Regression of lung and colon cancer xenografts by depleting or inhibiting RLIP76 (RALBP1)","volume":"67","author":"Singhal","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2017.03.009_bb0285","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0034582","article-title":"RLIP76 regulates PI3K\/Akt signaling and chemo-radio-therapy resistance in pancreatic cancer","volume":"7","author":"Leake","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.bbcan.2017.03.009_bb0290","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1158\/0008-5472.CAN-05-3534","article-title":"Regression of melanoma in a murine model by RLIP76 depletion","volume":"66","author":"Singhal","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2017.03.009_bb0295","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1093\/carcin\/bgs401","article-title":"RLIP76 is overexpressed in human glioblastomas and is required for proliferation, tumorigenesis and suppression of apoptosis","volume":"34","author":"Wang","year":"2013","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bbcan.2017.03.009_bb0300","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1593\/neo.101080","article-title":"RalBP1 is necessary for metastasis of human cancer cell lines","volume":"12","author":"Wu","year":"2010","journal-title":"Neoplasia"},{"key":"10.1016\/j.bbcan.2017.03.009_bb0305","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1158\/0008-5472.CAN-10-1517","article-title":"Activation and involvement of Ral GTPases in colorectal cancer","volume":"71","author":"Martin","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2017.03.009_bb0310","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s11060-013-1045-2","article-title":"Knockdown of RLIP76 expression by RNA interference inhibits invasion, induces cell cycle arrest, and increases chemosensitivity to the anticancer drug temozolomide in glioma cells","volume":"112","author":"Wang","year":"2013","journal-title":"J. Neuro-Oncol."},{"key":"10.1016\/j.bbcan.2017.03.009_bb0315","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1007\/s00210-003-0781-9","article-title":"Paclitaxel metabolism in rat and human liver microsomes is inhibited by phenolic antioxidants","volume":"368","author":"V\u00e1clav\u00edkov\u00e1","year":"2003","journal-title":"Naunyn Schmiedeberg's Arch. Pharmacol."},{"key":"10.1016\/j.bbcan.2017.03.009_bb0320","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0167-4838(93)90245-M","article-title":"Interactions of glutathione S-transferase \u03c0 with ethacrynic acid and its glutathione conjugate","volume":"1164","author":"Awasthi","year":"1993","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbcan.2017.03.009_bb0325","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1093\/jnci\/93.14.1062","article-title":"Blocking oncogenic Ras signaling for cancer therapy","volume":"93","author":"Adjei","year":"2001","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.bbcan.2017.03.009_bb0330","doi-asserted-by":"crossref","first-page":"3291","DOI":"10.1038\/sj.onc.1210422","article-title":"Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer","volume":"26","author":"Roberts","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2017.03.009_bb0335","doi-asserted-by":"crossref","first-page":"22473","DOI":"10.1074\/jbc.270.38.22473","article-title":"Bridging Ral GTPase to Rho pathways. RLIP76, a Ral effector with CDC42\/Rac GTPase-activating protein activity","volume":"270","author":"Jullien-Flores","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbcan.2017.03.009_bb0340","first-page":"2349","article-title":"A putative effector of Ral has homology to Rho\/Rac GTPase activating proteins","volume":"11","author":"Park","year":"1995","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2017.03.009_bb0345","doi-asserted-by":"crossref","first-page":"4578","DOI":"10.1128\/MCB.15.8.4578","article-title":"Identification and characterization of Ral-binding protein 1, a potential downstream target of Ral GTPases","volume":"15","author":"Cantor","year":"1995","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbcan.2017.03.009_bb0350","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/ncb728","article-title":"The exocyst is a Ral effector complex","volume":"4","author":"Moskalenko","year":"2002","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bbcan.2017.03.009_bb0355","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1073\/pnas.0808042106","article-title":"p53 represses c-Myc through induction of the tumor suppressor miR-145","volume":"106","author":"Sachdeva","year":"2009","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bbcan.2017.03.009_bb0360","first-page":"103","article-title":"Protection against 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine cytotoxicity and DNA adduct formation in human prostate by glutathione S-transferase P1","volume":"61","author":"Nelson","year":"2001","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.bbcan.2017.03.009_bb0365","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/nrc2090","article-title":"Inflammation in prostate carcinogenesis","volume":"7","author":"De Marzo","year":"2007","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbcan.2017.03.009_bb0370","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","article-title":"The hallmarks of cancer","volume":"100","author":"Hanahan","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2017.03.009_bb0375","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1126\/science.1203543","article-title":"A perspective on cancer cell metastasis","volume":"331","author":"Chaffer","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.bbcan.2017.03.009_bb0380","doi-asserted-by":"crossref","first-page":"30597","DOI":"10.1074\/jbc.M302191200","article-title":"RLIP, an effector of the Ral-GTPases, is a platform for Cdk1 to phosphorylate epsin during the switch off of endocytosis in mitosis","volume":"278","author":"Rosse","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbcan.2017.03.009_bb0385","doi-asserted-by":"crossref","first-page":"5915","DOI":"10.1038\/sj.onc.1202974","article-title":"Epsin binds to the EH domain of POB1 and regulates receptor-mediated endocytosis","volume":"18","author":"Morinaka","year":"1999","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2017.03.009_bb0390","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1242\/jcs.113.16.2837","article-title":"RLIP76, an effector of the GTPase Ral, interacts with the AP2 complex: involvement of the Ral pathway in receptor-endocytosis","volume":"113","author":"Jullien-Flores","year":"2000","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.bbcan.2017.03.009_bb0395","first-page":"5626","article-title":"Structure and expression of a human class pi glutathione S-transferase messenger RNA","volume":"47","author":"Kano","year":"1987","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2017.03.009_bb0400","doi-asserted-by":"crossref","first-page":"157","DOI":"10.4161\/sgtp.1.3.14233","article-title":"RLIP76 (RalBP1): the first piece of the structural puzzle","volume":"1","author":"Mott","year":"2010","journal-title":"Small GTPases"},{"key":"10.1016\/j.bbcan.2017.03.009_bb0405","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1016\/j.str.2013.09.007","article-title":"The structure of the RLIP76 RhoGAP-Ral binding domain dyad: fixed position of the domains leads to dual engagement of small G proteins at the membrane","volume":"21","author":"Rajasekar","year":"2013","journal-title":"Structure"},{"key":"10.1016\/j.bbcan.2017.03.009_bb0410","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1042\/BST20130231","article-title":"Structure and function of RLIP76 (RalBP1): an intersection point between Ras and Rho signalling","volume":"42","author":"Mott","year":"2014","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.bbcan.2017.03.009_bb0415","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1038\/aps.2009.94","article-title":"Silibinin inhibits prostate cancer invasion, motility and migration by suppressing vimentin and MMP-2 expression","volume":"30","author":"Wu","year":"2009","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.bbcan.2017.03.009_bb0420","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1093\/carcin\/bgm218","article-title":"Silibinin suppresses in vivo growth of human prostate carcinoma PC-3 tumor xenograft","volume":"28","author":"Singh","year":"2007","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bbcan.2017.03.009_bb0425","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1158\/0008-5472.CAN-06-3066","article-title":"Curcumin, a dietary component, has anticancer, chemo-sensitization, and radio-sensitization effects by down-regulating the MDM2 oncogene through the PI3K\/mTOR\/ETS2 pathway","volume":"67","author":"Li","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2017.03.009_bb0430","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.semcancer.2014.04.009","article-title":"Sorting it out: regulation of exosome loading","volume":"28","author":"Villarroya-Beltria","year":"2014","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.bbcan.2017.03.009_bb0435","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.clinthera.2014.04.018","article-title":"Potential of cancer cell\u2013derived exosomes in clinical application: a review of recent research advances","volume":"36","author":"Sun","year":"2014","journal-title":"Clin. Ther."},{"key":"10.1016\/j.bbcan.2017.03.009_bb0440","doi-asserted-by":"crossref","first-page":"5679","DOI":"10.1158\/1078-0432.CCR-10-1565","article-title":"Quercetin induces tumor-selective apoptosis through downregulation of Mcl-1 and activation of Bax","volume":"16","author":"Cheng","year":"2010","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2017.03.009_bb0445","article-title":"Phytochemicals in cancer prevention: a review of the evidence","author":"Meybodi","year":"2017","journal-title":"Iran J. Cancer Prev."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X17300446?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X17300446?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T04:22:40Z","timestamp":1759638160000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304419X17300446"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":89,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["S0304419X17300446"],"URL":"https:\/\/doi.org\/10.1016\/j.bbcan.2017.03.009","relation":{},"ISSN":["0304-419X"],"issn-type":[{"value":"0304-419X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting the mercapturic acid pathway and vicenin-2 for prevention of prostate cancer","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Reviews on Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbcan.2017.03.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}